Bimatoprost
Two bimatoprost products sit on this shelf: Bimat, a 0.3 mg bottle for lowering eye pressure in Open-angle Glaucoma, and Latisse Ophthalmic Solution, a 0.03% bottle applied to the eyelid margin to promote lash growth.
Latisse Ophthalmic Solution
Eyelash Hypotrichosis
0.03%
Bimatoprost solution for inadequate eyelashes. It extends the growth phase of each lash, so they become longer and denser.
Key points
- Bimatoprost is a prostaglandin analogue that lowers intraocular pressure by increasing fluid outflow from the eye.
- Both products contain bimatoprost alone, but the 0.3 mg eye drop and the 0.03% eyelid solution target different tissues and conditions.
- Bimatoprost can darken the eyelid skin and may permanently increase brown iris pigmentation; unwanted hair growth can occur where the topical solution repeatedly touches skin.
Common questions about Bimatoprost
Why do Bimat and Latisse contain the same ingredient but treat different conditions?
Bimatoprost works on prostaglandin receptors in the eye. At 0.3 mg, instilled into the eye, it increases fluid drainage and lowers pressure inside the globe. At 0.03%, applied to the upper eyelid margin, it stimulates hair follicles in the lash line. The concentration and the site of application determine which effect dominates.
What separates the two strengths on this shelf?
Bimat comes as a 0.3 mg bottle from Ajanta Pharma, listed for Eye Care conditions like glaucoma and Ocular Hypertension. Latisse Ophthalmic Solution is the 0.03% bottle, the brand-name version from Allergan, listed for eyelash hypotrichosis. The strengths, application sites and intended effects differ.